AI Terminal
Eckert & Ziegler Strahlen- und Medizintechnik AG
Board/Management Information • Aug 31, 2018
130_rns_2018-08-31_dc2911bc-4fbd-40f1-a836-3a88a72bda4c.html
Board/Management Information
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 31 August 2018 20:44
Dr. Lutz Helmke appointed as new director at Eckert & Ziegler Strahlen- und Medizintechnik AG; Dr. André Heß retires from director’s position
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Change of Personnel
Dr. Lutz Helmke appointed as new director at Eckert & Ziegler Strahlen- und Medizintechnik AG; Dr. André Heß retires from director’s position
31-Aug-2018 / 20:44 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Berlin, 31 August 2018. Today, the Supervisory Board of Eckert & Ziegler Strahlen- und Medizintechnik AG appointed Dr. Lutz Helmke as a new member of the Board of Directors of Eckert & Ziegler Strahlen- und Medizintechnik AG effective September 17, 2018. Dr. Helmke takes over as member of the Board of Directors, filling the position of the former director Dr. André Heß, whose appointment the Supervisory Board revokes effective immediately.
The Supervisory Board of Eckert & Ziegler Strahlen- und Medizintechnik AG and Dr. Helmke agreed on a director’s contract with terms of office until December 31, 2021.
Contact:
Eckert & Ziegler
Strahlen- und Medizintechnik AG
Karolin Riehle
Investor Relations
Robert-Rössle-Str. 10
13125 Berlin – Germany
Tel.: +49-30-94 10 84 138
Tel.: +49-30-94 10 84 112
E-mail: [email protected]
Information and Explanation of the Issuer to this News:
Dr. Helmke will manage Eckert & Ziegler Strahlen- und Medizintechnik AG together with
Dr. Andreas Eckert as the chairman of the Board of Directors and Dr. Harald Hasselmann as additional director.
Dr. Helmke, born in 1961, studied Mathematics and Chemistry at FU Berlin. After graduating from Radio Chemistry studies and receiving his PhD, he switched to Medical Technology and started his career in the marketing department of Biotronik. After that, he held various management positions at Abbott, St. Jude Medical, and most recently MagForce over a period of 25 years. As the head of various task forces within the German Federal Association for Medical Technology, Dr. Helmke also gained a wide range of experience in market launches and the reimbursement aspects of medical products. Dr. Helmke has three children and lives with his family in Berlin-Charlottenburg.
31-Aug-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | 49 30 941084-138 |
| Fax: | 49 30 941084-112 |
| E-mail: | [email protected] |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| End of Announcement | DGAP News Service |